Analysis of β cell differentiation in diabetic pancreas induced by betacellulin with special reference to the role of Pax family gene

β细胞素诱导糖尿病胰腺β细胞分化分析,特别关注Pax家族基因的作用

基本信息

  • 批准号:
    11671087
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

In the development of endocrine pancreas, various transcription factors that regulate the expression of growth and differentiation factors are involved. Among them, Pax family is known to have important role in the final differentiation of insulin-secreting β cells. On the other hand, little is known in the mechanism of neogenesis which occurs in the β cell depleted diabetic pancreas. We thus studied the process of β cell neogenesis with special reference to the expression of transcription factors including Pax family in pancreas of glucose intolerant mice induced by selective alloxan perfusion. We also tried to clarify the role of Pax 6 and 4 using dominant negative form of these genes introduced in AR42J cells. ICCs(Islet-like cell clusters) were observed closely associated with duct cell lining, and immunohistochemical analysis revealed that several kinds of transcription factors including PDX-1, Islet1, Nkx2.2 and Pax6 were expressed in some of duct cells and Icc cells, suggesting that Pax6 is involved in the β cell neogenesis in diabetic pancreas and the process of this type of regeneration (neogenesis) was similar to that of fetal endocrine cell development . However, Pax4 which is important for the final differentiation of β cells during development was undetectable level. Treatment with betacellulin , one of the growth factor of EGF family and is known to induce differentiation of AR42J cells into insulin-producing endocrine cells, increased the number of ICCs and ameliorate the glucose intolerance. To clarify the role of Pax4 and Pax6 in the β cell differentiation, we tried to make stable transformants of dominant negative form of these genes in AR42J cells, but this was difficult, and we could not analyze the roles of two Pax genes in β cell differentiation using in vitro experimental system.
在内分泌胰腺的发育过程中,涉及多种调节生长和分化因子表达的转录因子。其中,已知Pax家族在胰岛素分泌β细胞的最终分化中起重要作用。另一方面,在β细胞衰竭的糖尿病胰腺中发生的新生机制知之甚少。因此,我们研究了选择性四氧嘧啶灌注诱导葡萄糖不耐受小鼠胰腺β细胞新生的过程,特别参考了Pax家族等转录因子的表达。我们还试图通过引入AR42J细胞的显性阴性形式来阐明Pax 6和4的作用。胰岛样细胞群(ICCs)与胰管细胞内层密切相关,免疫组化分析显示,部分胰管细胞和胰管细胞中表达PDX-1、胰岛样细胞1、Nkx2.2、Pax6等转录因子,提示Pax6参与了糖尿病胰腺β细胞的新生,这种再生(新生)过程与胎儿内分泌细胞的发育过程相似。然而,在发育过程中对β细胞最终分化至关重要的Pax4未检测到。β细胞素是EGF家族的生长因子之一,已知可诱导AR42J细胞分化为产生胰岛素的内分泌细胞,增加ICCs的数量并改善葡萄糖耐受不良。为了明确Pax4和Pax6在β细胞分化中的作用,我们试图在AR42J细胞中构建这些基因显性阴性形式的稳定转化子,但这很困难,并且我们无法使用体外实验系统分析两个Pax基因在β细胞分化中的作用。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y.: "A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence."Ann Med. 32. 527-531 (2000)
今川 A.、花房 T.、宫川 J.、松泽 Y.:“根据临床和病理证据提出 1 型糖尿病的三种不同亚型的建议。”Ann Med。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
今川彰久,森脇信,花房俊昭,宮川潤一郎: "1型糖尿病膵の細胞生物学と病態"細胞. 32・12. 448-451 (2000)
今川明久、森胁诚、花房俊明、宫川润一郎:“1 型糖尿病胰腺的细胞生物学和病理学”32・12(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
宮川潤一郎,山本浩司: "膵β細胞の再生促進療法"Molecular Medicine. 38・1. 62-67 (2001)
宫川纯一郎、山本浩二:“促进胰腺β细胞再生的治疗”《分子医学》38・1(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto K., Miyagawa J., Waguri M., Sasada R., Igarashi K., Li M., Nammo T., Moriwaki M., Imagawa A., Yamagata K., Nakajima H., Namba M., Hanafusa T., Matsuzawa Y.: "Recombinant human betacellulin promotes neogenesis of β-Cells and ameliorates glucose in
山本 K.、宫川 J.、Waguri M.、笹田 R.、五十岚 K.、李 M.、南莫 T.、森胁 M.、今川 A.、山形 K.、中岛 H.、难波 M.、花房 T ., Matsuzawa Y.:“重组人β细胞素可促进 β 细胞的新生并改善血糖水平
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sawada-Hase N., Kiyohara T., Miyagawa J., Ueyama H., Nishibayashi H., Murayama Y., Kashihara T., Nakahara M., Miyazaki Y., Kanayama S., Nezu R., Shinomura Y., Matsuzawa Y.: "An increased number of CD40 high monocytes discriminate Crohn's disease from ulce
泽田长濑 N.、清原 T.、宫川 J.、上山 H.、西林 H.、村山 Y.、橿原 T.、中原 M.、宫崎 Y.、金山 S.、根津 R.、筱村 Y.、
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIYAGAWA Jun-ichiro其他文献

MIYAGAWA Jun-ichiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIYAGAWA Jun-ichiro', 18)}}的其他基金

Mechanism of differentiation and growth of pancreatic βcells by newly identified growth factor, NTAK, and its application for regenerative medicine in diabetes mellitus
新发现的生长因子NTAK诱导胰腺β细胞分化和生长的机制及其在糖尿病再生医学中的应用
  • 批准号:
    18591006
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of regeneration therapy for type 1 diabetes by induction of β cell neogenesis
通过诱导 β 细胞新生开发 1 型糖尿病再生疗法
  • 批准号:
    13671154
  • 财政年份:
    2001
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of the method for gene therapy of β cell regeneration by non-invasive gene delivery via pancreatic duct
胰管非侵入性基因递送促进β细胞再生的基因治疗方法的建立
  • 批准号:
    12557089
  • 财政年份:
    2000
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on the beta cell differentiation signal in AR42J cells and in vivo effect on islet neogenesis in diabetic mice by betacellulin
AR42J细胞β细胞分化信号及βcellulin对糖尿病小鼠胰岛新生作用的体内研究
  • 批准号:
    09671056
  • 财政年份:
    1997
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
  • 批准号:
    24K19287
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Community-based Preconception Lifestyle Intervention to prevent Gestational Diabetes Mellitus in Women living in India
以社区为基础的孕前生活方式干预,以预防印度妇女妊娠期糖尿病
  • 批准号:
    494564
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Linoleic acid-derived oxylipin species and cognitive function in type 2 diabetes mellitus
亚油酸衍生的氧脂素种类与 2 型糖尿病的认知功能
  • 批准号:
    495437
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
  • 批准号:
    23K06224
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathophysiological analysis of the beta cell volume change elicited by pregnancy and gestational diabetes mellitus in Japanese pregnant women
日本孕妇妊娠和妊娠糖尿病引起的β细胞体积变化的病理生理学分析
  • 批准号:
    23K08020
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis
CXCL10-CXCR3轴在糖尿病牙周炎复合作用中的作用
  • 批准号:
    10740433
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
The Study of the Association between Gestational Diabetes Mellitus and Mental Health during Pregnancy in Japanese Women
日本女性妊娠期糖尿病与孕期心理健康关系的研究
  • 批准号:
    23K10101
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized diet therapy useful for glycemic control and quality of life in patients with type 1 diabetes mellitus
个性化饮食疗法有助于 1 型糖尿病患者的血糖控制和生活质量
  • 批准号:
    23K10809
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidating the Pathophysiology of Gestational Diabetes Mellitus
阐明妊娠糖尿病的病理生理学
  • 批准号:
    10738361
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了